[Isl] FW: Funding Opportunity ~ Alzheimer's

Neil Charness charness at psy.fsu.edu
Tue Jun 18 19:12:50 EDT 2019


Hi Folks:

For those interested in Alzheimer's funding opportunities see below.  Best, Neil

Neil Charness, Ph.D., William G. Chase Professor of Psychology
Director, Institute for Successful Longevity www.isl.fsu.edu<http:// www.isl.fsu.edu>
Department of Psychology, Florida State University
1107 West Call Street, Tallahassee, Florida, USA 32306-4301
Phone (office): 850-644-6686; Fax: 850-644-7739
E-mail: charness at psy.fsu.edu<mailto:charness at psy.fsu.edu>; http://www.psy.fsu.edu/~charness/
Please Note:
Due to Florida's very broad public records law, most written business communications to or from FSU staff and/or any public college or university employee are public records, available to the public and media upon request. Therefore, this e-mail communication may be subject to public disclosure.

From: Office of Proposal Development Announcements <opd at fsu.edu>
Sent: Tuesday, June 18, 2019 2:13 PM
To: Neil Charness <charness at psy.fsu.edu>; Antonio Terracciano <aterracciano at fsu.edu>
Cc: Rachel Goff-Albritton <r.goffalbritton at fsu.edu>; Ana-Marie Seiple <aseiple at fsu.edu>
Subject: Funding Opportunity ~ Alzheimer's


Greetings,



Below are some funding opportunities that may be of interest to you or your faculty.  If this is not in your specific area, but you have colleagues who may be interested, please pass along.  We look forward to helping you fund and grow your research and creativity!
_________________________________________________________________________________________________________________________________________



Department of Health and Human Services

National Institutes of Health

Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications that seek to enhance existing transcriptome and proteome data sets by revealing oscillatory patterns of gene expression in aging and in Alzheimer's disease (AD), by uncovering their molecular significance, and by identifying rhythmic gene and/or protein profiles associated with the risk for AD.

Letter of Intent Due Date: Sep 23, 2019

https://urldefense.proofpoint.com/v2/url?u=https-3A__www.grants.gov_web_grants_view-2Dopportunity.html-3FoppId-3D316555&d=DwIFaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=5vmtJSGT525Hq4ToZvrUdA&m=54RlP27V660aG4En2tw0EYFFrKmnpPAk9KWma1_ECGs&s=gDJPWUNp5wuSILcjAJFJfMaRXjb5nX5TSVumpf1fAcE&e=

--
Alzheimer's Drug Discovery Foundation
Innovative Dementia Pharmacologic Interventions
The Alzheimer's Drug Discovery Foundation seeks to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer's disease and related dementias. To that end, grants of up to $5 million will be awarded in support of research on innovative pharmacologic interventions for Alzheimer's disease and related dementias, including clinical trials, regulatory studies for novel drugs (small molecules and biologics, including antibodies, peptides, gene therapies), repurposed drugs (existing drugs that are approved for other diseases and conditions), repositioned drugs (existing drugs that have entered clinical trials for other indications and have not yet been approved), and natural products.
Letter of Intent Due Date: Jul 12 2019
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/pact
--
Alzheimer's Drug Discovery Foundation
Clinical Trials, Epidemiological Studies
The Alzheimer's Drug Discovery Foundation (ADDF) is inviting applications to its Prevention Beyond the Pipeline program. Through the program, awards will be made in support of comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Grants of up to $100,000 over one year will be awarded for epidemiological analysis and grants of up to $3 million over a variable number of years will be awarded for clinical trials.
Letter of Intent Due Date: Jul 12 2019
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/prevention-beyond-the-pipeline

_______________________________________________________________________________________________________________________________________



Why were you selected to receive this email?

You or your faculty were identified based on your strategic position OR by keywords in the Faculty Expertise and Advancement System (FEAS) Profile. Thank you for keeping your FEAS Profile updated.



Interested in this opportunity?

The Office of Proposal Development provides FSU faculty with grants consulting services including:



*             Proposal Editing

*             Collaborator Identification

*             Proposal Team Coordination

*             Examples of Successful Proposals

*             Strategic Planning



For more information visit us at http://opd.fsu.edu<http://opd.fsu.edu/>



Sincerely,



Belton Morgan

Student Assistant

Office of Proposal Development

20022 Westcott North Annex

Tallahassee, FL 32306-1330



Florida State University

bmorgan2 at fsu.edu<mailto:bmorgan2 at fsu.edu>

https://www.research.fsu.edu/research-offices/opd/

[cid:image001.png at 01D525DF.F1CE46E0]

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.fsu.edu/pipermail/isl/attachments/20190618/51f3d12a/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 7589 bytes
Desc: image001.png
URL: <http://lists.fsu.edu/pipermail/isl/attachments/20190618/51f3d12a/attachment.png>


More information about the Isl mailing list